Qaelon Medical is a pioneering startup specializing in advanced solutions for minimally invasive surgery. Founded in December 2020 as a spin-off from the IHU Strasbourg, the company focuses on developing cutting-edge technologies to enhance surgical outcomes. The core product of Qaelon Medical is an innovative intraoperative leak detection system, designed to identify leaks during minimally invasive procedures. This technology aims to set a new standard in the field, ensuring higher precision and safety for patients.

The company serves a diverse range of clients, primarily targeting hospitals, surgical centers, and healthcare professionals who perform minimally invasive surgeries. By providing a reliable method for leak detection, Qaelon Medical addresses a critical need in the medical field, reducing the risk of postoperative complications and improving patient recovery times.

Qaelon Medical operates in the medical technology market, a rapidly growing sector driven by advancements in healthcare and increasing demand for minimally invasive surgical techniques. The company's business model revolves around the development, manufacturing, and sale of its proprietary leak detection systems. Revenue is generated through the direct sale of these systems to healthcare institutions and through partnerships with medical device distributors.

The interdisciplinary team at Qaelon Medical, led by CEO Thierry Sarda, CMO Dr. Eran Shlomovitz, CTO Fabienne Betting, and COO Yee Ying Douchamps, brings together expertise from various fields to drive innovation and excellence. Their collective experience and commitment to improving surgical practices position Qaelon Medical as a leader in the industry.

Keywords: Minimally Invasive Surgery, Leak Detection, Medical Technology, Healthcare Innovation, Surgical Safety, Intraoperative Solutions, Patient Outcomes, Medical Devices, Healthcare Professionals, Advanced Surgery.